Literature DB >> 2513101

Anemia and cancer.

D Steinberg1.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2513101     DOI： 10.3322/canjclin.39.5.296

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  5 in total

1.  [Bone marrow carcinosis as initial presentation of adenocarcinoma].

Authors:  C List; St Parmentier; S Jahn; U Schuler; F Kroschinsky
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

2.  Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study.

Authors:  Erica Quaquarini; Federico Sottotetti; Francesco Agustoni; Emma Pozzi; Alberto Malovini; Cristina Maria Teragni; Raffaella Palumbo; Giuseppe Saltalamacchia; Barbara Tagliaferri; Emanuela Balletti; Pietro Rinaldi; Costanza Canino; Paolo Pedrazzoli; Antonio Bernardo
Journal:  J Pers Med       Date:  2022-04-24

3.  Routine blood tests and probability of cancer in patients referred with non-specific serious symptoms: a cohort study.

Authors:  Esben Næser; Henrik Møller; Ulrich Fredberg; Jan Frystyk; Peter Vedsted
Journal:  BMC Cancer       Date:  2017-12-04       Impact factor: 4.430

4.  Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance.

Authors:  Albert J van Hell; Manuel N Melo; Wim J van Blitterswijk; Dayana M Gueth; Tanya M Braumuller; Lilia R C Pedrosa; Ji-Ying Song; Siewert J Marrink; Gerben A Koning; Jos Jonkers; Marcel Verheij
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

5.  Relationships between Exercise Modality and Activity Restriction, Quality of Life, and Hematopoietic Profile in Korean Breast Cancer Survivors.

Authors:  MunHee Kim; Wi-Young So; Jiyoun Kim
Journal:  Int J Environ Res Public Health       Date:  2020-09-21       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.